CLPBY (Coloplast AS) YoY EBITDA Growth : 11.02% (As of Sep. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Coloplast AS YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Coloplast AS's YoY EBITDA Growth for the quarter that ended in Sep. 2024 was 11.02%.

Coloplast AS's EBITDA per Share for the three months ended in Sep. 2024 was $0.14.

Coloplast AS YoY EBITDA Growth Historical Data

The historical data trend for Coloplast AS's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS YoY EBITDA Growth Chart

Coloplast AS Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

YoY EBITDA Growth

Get a 7-Day Free Trial

19.54

11.04

-13.58

13.50

9.36

Coloplast AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
YoY EBITDA Growth	Get a 7-Day Free Trial															3.25	12.40	3.76	2.17	11.02

Coloplast AS YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Coloplast AS's YoY EBITDA Growth for the fiscal year that ended in Sep. 2024 is calculated as:

	YoY EBITDA Growth (A: Sep. 2024 )
=	(EBITDA per Share (A: Sep. 2024 )	-	EBITDA per Share (A: Sep. 2023 ))	/	\| EBITDA per Share (A: Sep. 2023 ) \|
=	(0.561	-	0.513)	/	\| 0.513 \|
=	9.36 %

Coloplast AS's YoY EBITDA Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY EBITDA Growth (Q: Sep. 2024 )
=	(EBITDA per Share (Q: Sep. 2024 )	-	EBITDA per Share (Q: Sep. 2023 ))	/	\| EBITDA per Share (Q: Sep. 2023 )) \|
=	(0.141	-	0.127)	/	\| 0.127 \|
=	11.02 %

Coloplast AS YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Coloplast AS's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Coloplast AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OTCPK:CLPBY) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

CLPBF:USA COLOBc:UK 0QBO:UK COLO B:Denmark CBH:Germany

Address

Holtedam 1-3, Humlebaek, DNK, DK-3050

Website

https://www.coloplast.com

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.